We are live on ! Find out more
APDNW

Applied DNA Sciences Inc Warrant

Delisted

APDNW was delisted on the 18th of November, 2019.

6 hedge funds and large institutions have $870K invested in Applied DNA Sciences Inc Warrant in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 66 (0)

25% less capital invested

Capital invested by funds: $1.16M → $870K (-$289K)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
6
Holders Change
Holders Change %
0%
% of All Funds
0.15%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
3
Closed
Calls
Puts
Net Calls
Net Calls Change

APDNW Hedge Fund Activity: Q3 2017 in Review

6 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Applied DNA Sciences Inc Warrant (APDNW) for Q3 2017, worth a combined $870K — down 25% from $1.16M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new APDNW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 3 trimmed.

The largest buyer was CIBC Private Wealth Group, opening a new position worth an estimated $9.17K. The largest seller was Sabby Management, cutting an estimated $731K.

  • 6 institutional investors held Applied DNA Sciences Inc Warrant (APDNW) as of Q3 2017, unchanged from Q2 2017.
  • Funds reported $870K of Applied DNA Sciences Inc Warrant stock for Q3 2017, down 25% quarter-over-quarter.
  • 1 fund opened new Applied DNA Sciences Inc Warrant positions in Q3 2017 and 0 closed out, a net change of +1 holder.
  • The largest Applied DNA Sciences Inc Warrant buyer in Q3 2017 was CIBC Private Wealth Group, an estimated $9.17K added.
  • The largest Applied DNA Sciences Inc Warrant seller in Q3 2017 was Sabby Management, an estimated $731K sold.

Based on aggregated 13F filings for Q3 2017.